icon-close
fren

Also in this section

2025-2029 Research Funding Competition

SCN’s national research funding competition supports world-class, translational, regenerative medicine research, across the research continuum, to facilitate health, social and economic benefits for Canadians.

Research Funding Opportunities – The 2025 Call for Full Applications is Now Closed. The next funding competition will open in the Fall of 2026.

Check out the results from the 2025 Research Funding Competition here!

If you missed the 2025 opportunity, we encourage you to stay connected with SCN for future funding calls. Please check back regularly or subscribe to our newsletter for updates on upcoming funding opportunities.

For background, the Stem Cell Network launched the first of two national research funding competitions for the 2025-2029 funding cycle. The Round 1 competition opened on Tuesday, September 3, 2024, and offered both 24- and 36-month awards. Six regenerative medicine research programs were available that focused on innovation, clinical translation, policy and societal impact and commercialization.

New in 2025, SCN was proud to collaborate with three organizations to offer joint-funding award opportunities. These organizations are:

The six programs are:

Accelerating Clinical Translation Awards
SCN will provide up to $650,000 to support multi-disciplinary research that is moving towards the clinic within five years; or is addressing a key research question associated with an ongoing clinical trial.

  • Joint-Funded Awards valued at $780K are also available in collaboration with Azrieli Foundation or Breakthrough T1D for this program

Clinical Trial Awards
SCN will provide up to $1,100,000 to support early-stage clinical trial projects with high translational potential.

  • Joint-Funded Awards valued at $1,320,000 are also available in collaboration with Azrieli Foundation or Breakthrough T1D for this program

Early Career Researcher Jump Start Awards
SCN will provide up to $350,000 for early career researchers (within the first five years of an initial academic appointment) to develop a research program with a regenerative medicine focus.

  • Joint-Funded Awards valued at $420K are also available in collaboration with Azrieli Foundation for this program

Fueling Biotechnology Partnerships Awards
SCN will provide up to $430,000 to support academic partnerships with emerging Canadian regenerative medicine biotechnology companies to bring innovative technologies or therapies to the clinic or market.

  • Joint-Funded Awards of $500K and $516K are also available in collaboration with CQDM or Breakthrough T1D for this program

Impact Awards
SCN will provide up to $270,000 to support proof-of-principle experiments, including novel therapeutic or technical approach development that will drive regenerative medicine therapies forward.

  • Joint-Funded Awards valued at $324K are also available in collaboration with Azrieli Foundation or Breakthrough T1D for this program

Impact Awards: Ethical, Legal and Social Implications (ELSI) & Health Economics (HE) Stream
SCN will provide up to $215,000 to support studies focused on the ethical, legal, social, and health economic implications of regenerative medicine.

  • Joint-Funded Awards valued at $258K are also available in collaboration with Azrieli Foundation or Breakthrough T1D for this program

To view previous funding competition results, visit our Funded research database page.